Hi NZT and all,
Your thoughts on this please.
The profit margin on orphan drugs is higher than the pharmaceutical industry average. Orphan drugs are reported to have a gross profit margin of over 80%, whereas the pharmaceutical industry average is 16%5. This higher profit margin is attributed to factors such as higher pricing, market exclusivity, and incentives related to research and development . Publicly listed pharmaceutical companies that are orphan drug market authorization holders are associated with higher market value and greater profits than companies not producing treatments for rare diseases.
Kpax
Hi NZT and all,Your thoughts on this please.The profit margin on...
-
- There are more pages in this discussion • 396 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $89.95M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.5¢ | $111.6K | 601.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 169572 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 613756 | 10 |
View Market Depth
| Last trade - 15.46pm 30/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |